No disclosed counterparties: RS, RYZ.
| Stage | RS | % of rev | RYZ | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.2B | 100.00% | $2.2B | 100.00% | RS ×2.39 |
| Gross profit | $1.5B | 27.89% | $374M | 17.16% | RS +10.7pp |
| Operating income | $552M | 10.59% | $52M | 2.36% | RS +8.2pp |
| Pre-tax income | $532M | 10.20% | $36M | 1.67% | RS +8.5pp |
| Net income | $403M | 7.74% | $33M | 1.49% | RS +6.2pp |
| Stage | RS | RYZ | Gap · A − B |
|---|---|---|---|
| Revenue | $5.2B100.00% | $2.2B100.00% | RS ×2.39 |
| Gross profit | 27.89%$1.5B | 17.16%$374M | RS +10.7pp |
| Operating income | 10.59%$552M | 2.36%$52M | RS +8.2pp |
| Pre-tax income | 10.20%$532M | 1.67%$36M | RS +8.5pp |
| Net income |
| 7.74%$403M |
| 1.49%$33M |
| RS +6.2pp |